Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > gp140

gp140

Brief Information

Name:Transmembrane glycoprotein gp140
Target Synonym:
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
GP0-V82E3 Human immunodeficiency virus 1 (HIV-1) Biotinylated Human immunodeficiency virus 1 gp140 Protein, His,Avitag™ (MALS verified)
GP0-V82E3-sds
GP0-V52H3 Human immunodeficiency virus 1 (HIV-1) Human immunodeficiency virus 1 gp140 Protein, His Tag (MALS verified)
GP0-V52H3-sds
ACRO Quality

Part of Bioactivity data

GP0-V52H3-ELISA
 gp140 ELISA

Immobilized Human CD4 Protein, Fc Tag (Cat. No. CD4-H5259) at 5 μg/mL (100 μL/well) can bind Human immunodeficiency virus 1 gp140 Protein, His Tag (Cat. No. GP0-V52H3) with a linear range of 0.005-0.156 μg/mL (QC tested).

GP0-V82E3-MALS-HPLC
gp140 MALS images

The purity of Biotinylated Human immunodeficiency virus 1 gp140 Protein, His,Avitag (Cat. No. GP0-V82E3) is more than 85% and the molecular weight of this protein is around 355-385 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
N332-GT5 gp140 N332-GT5 gp140 Phase 1 Clinical National Institute Of Allergy And Infectious Diseases (Niaid) HIV Infections; HIV Seropositivity Details
N332-GT5 gp140 N332-GT5 gp140 Phase 1 Clinical National Institute Of Allergy And Infectious Diseases (Niaid) HIV Infections; HIV Seropositivity Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message